G. Anthony Quinn's Insider Trades & SAST Disclosures
G. Anthony Quinn's most recent trade in Generation Bio Co was a trade of 125,791 Common Stock done at an average price of $1.0 . Disclosure was reported to the exchange on Jan. 10, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern G. Anthony Quinn.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Generation Bio Co | Anthony G. Quinn | Director | Purchase of securities on an exchange or from another person at price $ 0.96 per share. | 10 Jan 2025 | 125,791 | 214,286 | - | 1.0 | 120,759 | Common Stock |
| Generation Bio Co | Anthony G. Quinn | Director | Purchase of securities on an exchange or from another person at price $ 0.97 per share. | 10 Jan 2025 | 85,000 | 299,286 | - | 1.0 | 82,450 | Common Stock |
| Generation Bio Co | Anthony G. Quinn | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2024 | 60,000 | 60,000 | - | - | Stock Option (right to buy) | |
| Generation Bio Co | G. Anthony Quinn | Director | Purchase of securities on an exchange or from another person at price $ 1.41 per share. | 01 Dec 2023 | 88,495 | 88,495 | - | 1.4 | 124,778 | Common Stock |
| Generation Bio Co | Anthony G. Quinn | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2023 | 25,000 | 25,000 | - | - | Stock Option (right to buy) | |
| Generation Bio Co | Anthony G. Quinn | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2022 | 19,200 | 19,200 | - | - | Stock Option (right to buy) | |
| Aeglea BioTherapeutics Inc | Anthony G. Quinn | Director, President & CEO | Purchase of securities on an exchange or from another person at price $ 2.34 per share. | 16 Mar 2022 | 80,079 | 550,540 (1%) | 0% | 2.3 | 187,705 | Common Stock |
| Aeglea BioTherapeutics Inc | Anthony G. Quinn | Director, President & CEO | Purchase of securities on an exchange or from another person at price $ 1.93 per share. | 11 Mar 2022 | 67,472 | 431,044 (1%) | 0% | 1.9 | 130,221 | Common Stock |
| Aeglea BioTherapeutics Inc | Anthony G. Quinn | Director, President & CEO | Purchase of securities on an exchange or from another person at price $ 1.86 per share. | 11 Mar 2022 | 42,417 | 473,461 (1%) | 0% | 1.9 | 78,942 | Common Stock |
| Aeglea BioTherapeutics Inc | Anthony G. Quinn | Director, President & CEO | Purchase of securities on an exchange or from another person at price $ 2.06 per share. | 11 Mar 2022 | 34,777 | 363,572 (1%) | 0% | 2.1 | 71,780 | Common Stock |
| Aeglea BioTherapeutics Inc | Anthony G. Quinn | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Feb 2022 | 350,000 | 350,000 | - | - | Employee Stock Option (right to buy) | |
| Aeglea BioTherapeutics Inc | Anthony G. Quinn | Director, President & CEO | Purchase of securities on an exchange or from another person at price $ 3.70 per share. | 09 Dec 2021 | 43,108 | 318,269 (1%) | 0% | 3.7 | 159,500 | Common Stock |
| Aeglea BioTherapeutics Inc | Anthony G. Quinn | Director, President & CEO | Purchase of securities on an exchange or from another person at price $ 3.75 per share. | 09 Dec 2021 | 10,526 | 328,795 (1%) | 0% | 3.8 | 39,473 | Common Stock |
| Generation Bio Co | Anthony G. Quinn | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 28 Oct 2021 | 72,837 | 0 | - | 0 | Common Stock | |
| Generation Bio Co | Anthony G. Quinn | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 28 Oct 2021 | 72,837 | 72,837 | - | 0 | Common Stock | |
| Generation Bio Co | Anthony G. Quinn | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2021 | 15,000 | 15,000 | - | - | Stock Option (right to buy) | |
| Aeglea BioTherapeutics Inc | Anthony G. Quinn | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Feb 2021 | 330,000 | 330,000 | - | - | Employee Stock Option (right to buy) | |
| Generation Bio Co | Anthony G. Quinn | Director | 16 Jun 2020 | 53,654 | 0 | - | - | Series C Preferred Stock | ||
| Generation Bio Co | Anthony G. Quinn | Director | 16 Jun 2020 | 30,376 | 72,837 | - | - | Common Stock | ||
| Generation Bio Co | Anthony G. Quinn | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2020 | 52,000 | 52,000 | - | - | Stock Option (right to buy) |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges